A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma. - Wikidata - wikimedia - TriplyDB

A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma.

A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma.

http://www.wikidata.org/entity/Q39483693

about

Marrow-Infiltrating Lymphocytes - Role in Biology and Cancer Therapy The role and regulation of human Th17 cells in tumor immunity Immunotherapy strategies for multiple myeloma: the present and the future T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor Cells High IL-17 expression is associated with an unfavorable prognosis in thyroid cancer Bone disease in multiple myeloma: pathophysiology and management.Cytokine-mediated bone destruction in rheumatoid arthritis.Bone-immune cell crosstalk: bone diseases.The immune microenvironment of myeloma Pathogenesis beyond the cancer clone(s) in multiple myeloma.Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma.Bone marrow and the control of immunity.The cellular immune system in myelomagenesis: NK cells and T cells in the development of myeloma [corrected] and their uses in immunotherapies.Haematological malignancies: at the forefront of immunotherapeutic innovation.Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance.The role of Interleukin-17A and Interleukin-17E in multiple myeloma patients High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma.Lenalidomide-induced immunomodulation in multiple myeloma: impact on vaccines and antitumor responses.Cellular mechanisms of multiple myeloma bone disease The Interplay between the bone and the immune system Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance.Spontaneous onset and transplant models of the Vk*MYC mouse show immunological sequelae comparable to human multiple myeloma.Th17 and Treg cells in bone related diseases.The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.Contributions of the host microenvironment to cancer-induced bone disease.The bone marrow stroma in hematological neoplasms--a guilty bystander.Can we change the disease biology of multiple myeloma?Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy.Immunologic microenvironment and personalized treatment in multiple myeloma.Signaling between tumor cells and the host bone marrow microenvironment.Immunological dysregulation in multiple myeloma microenvironment.The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis.Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities.Mechanisms of osteolytic and osteoblastic skeletal lesions.Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies.Molecular mechanisms, current management and next generation therapy in myeloma bone disease.The osteoimmunology of alveolar bone loss.Role of the Immune Response in Disease Progression and Therapy in Multiple Myeloma.

P2860

Q26749560-3F5C6E9A-F411-4C0C-B95F-03F1DC54E556 Q27011396-A58EC01C-BC48-44AF-AC79-8B46C65C5D5B Q27021939-65C22FFB-EA87-4A04-82E3-F3AFAF55C902 Q27311542-11AB4F9D-1A83-4C11-8C78-65E11097559D Q28083973-FEBCABCA-E5D0-4BC1-A3D7-D07929AFB50B Q33597831-FC42E886-5A0A-4AA5-9733-52EFE4C88360 Q34045789-6CB999AC-8F2D-4BE1-BA48-838F56031614 Q34252489-524CD510-E627-45B6-A9C2-769B8DFDB61B Q35592362-CE1DAB83-6917-4541-B31F-38F89FBA799E Q35603152-5457287B-A36B-421F-9A0B-0B812C3795FC Q35607266-7795A5C5-6BDD-41EC-ACAC-9326F6102844 Q35623772-0DE01EEC-C420-45A5-BC74-4DB8AF2DD8A9 Q35653129-8E48F0AC-5BA0-40BD-969B-4070B31D923B Q35669068-162F0F5A-8FDA-45FF-BF2B-04D79D956A9F Q35880618-CBD62591-90FF-4478-B86F-D9605B75B48C Q35944713-660FC001-F2E4-4E2A-AAE3-F948EA6EDE84 Q36577172-0B98547C-8758-4234-A636-2ECD2034E60F Q36750576-5B151C64-50B3-4D30-9F9A-A554B3158EB7 Q36806619-6FFDDC29-08A3-4C1F-8397-9CC2BC7B033A Q36925346-00DCC611-FDC3-4161-B8E0-B76598C83381 Q37052226-DEFE1B77-A427-4401-A067-07CC99352FE9 Q37212043-FB4F2FDB-B304-4CA0-98CA-55B5264C5B31 Q37233276-BC60ED23-F2B8-4C53-B090-D5D76F23D380 Q37239790-6C6702AB-B4E8-472E-9320-BBBA6E37AD92 Q37517482-354EEC2D-1DBD-428C-BF62-0428DB99B6C4 Q37663962-5DD0F0C2-CFC1-4912-8B8D-AA3CCFC9272E Q37859253-B9670DD0-B71B-4EC8-AE24-D0F051CFF59B Q38062038-F00319BA-2022-4720-96B4-61ECE3AC9FE4 Q38074017-ED06E741-8733-42E5-A180-9B12236105EE Q38108390-36AB7BFA-419F-43A3-A4C7-9DC40FF92E32 Q38138849-3392C509-D46F-4B33-93F6-D78E55C4CBD1 Q38228353-671D7B39-4BC8-4EB3-9E07-48AD4B0C0F5A Q38238738-64E3A373-D04A-47AF-9EF7-2AA260CBD570 Q38255161-F344E800-9CE3-45F5-9E4D-093AFA4A0444 Q38299932-B4EC7571-69BE-4A6D-8F93-A16F805C29D6 Q38625793-0271FF56-17FC-4032-8C76-8160343ABDE1 Q38708402-342689BD-1758-48DF-838E-CF118B61CDB1 Q38749233-81260EF9-244C-4305-B744-1783B849BCB7 Q38763612-4D62DB67-53DF-47D4-893D-0F9C5424DDC3 Q38815399-1B00474C-77A0-41BA-B247-5842E2C5AB32

P2860

A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma.

http://www.wikidata.org/entity/Q39483693

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

A novel role of IL-17-producin ...... e disease in multiple myeloma.

@en

A novel role of IL-17-producin ...... e disease in multiple myeloma.

@nl

type

label

A novel role of IL-17-producin ...... e disease in multiple myeloma.

@en

A novel role of IL-17-producin ...... e disease in multiple myeloma.

@nl

prefLabel

A novel role of IL-17-producin ...... e disease in multiple myeloma.

@en

A novel role of IL-17-producin ...... e disease in multiple myeloma.

@nl

P1433

Q39483693-ED45D9B1-52D5-4603-B38E-6B911A906E8F

P1476

Q39483693-9BAB2F61-63A3-42FA-9FA0-3AD6445F5C5B

P2093

Q39483693-4A6C2518-88C4-47BC-84FF-D71819924417

Q39483693-5AD592E3-A613-4419-AA58-E43B57E10180

Q39483693-73EA079B-5B38-4ECA-BAE8-76633B7CB337

Q39483693-8810A1FB-C5F4-48C3-8C3F-7AE8DA81DF86

Q39483693-9A18656E-CFBD-4157-81BC-C9C2339C1E48

P2860

Q39483693-04A006B4-4172-4286-B568-703883E6B49C

Q39483693-0FE082D2-B63B-46D7-9810-D783EE714D20

Q39483693-1B65B6FA-206A-436F-8211-E826C5AAE1A1

Q39483693-2678978E-BB3A-46AB-881B-C95D3821E37C

Q39483693-27157E12-AB8C-49AF-9086-A0644C7B78A0

Q39483693-2A284E63-4D5E-4272-9DE5-6E1C11C4D530

Q39483693-33F1DCC8-F7DE-496C-ABB9-5D94866B3CC3

Q39483693-38529981-981D-4127-B28C-70DEC7A7DFA8

Q39483693-38B28543-4D2B-4EAB-855C-110B193E0BA4

Q39483693-43A5A6BA-95E6-4CF1-9AF4-851419716063

P304

Q39483693-5D568BEE-4E0C-48A2-B5FA-D032FB433D6C

P31

Q39483693-85304E1C-3A68-4C19-9583-089291DAF7AA

P356

Q39483693-D19A191A-7CDB-4DB5-B19E-46E1A17913FA

P407

Q39483693-DE57DCE6-FB36-40DD-AA02-E82520053B40

P433

Q39483693-5927CA3B-913D-48E6-8BBD-0FF6D97560AD

P478

Q39483693-3C1BE540-FACC-4859-9DA1-ED2CF0FEE214

P50

Q39483693-C4F85129-D7E8-44A6-93E0-C6B9C47200BE

P577

Q39483693-F4BDBE9E-9DBC-49C0-BA70-D33F73964A35

P5875

Q39483693-053EC47F-526C-4014-9D54-C6DA56A130E2

P698

Q39483693-054A5D00-2229-4F00-95B1-3D53CBBA98EE

P921

Q39483693-D5E06282-55FA-49AF-B610-7597B9323D08

P932

Q39483693-D98B8984-ED09-4BD4-B36A-77BD7D9986A6

P356

BLOOD-2010-05-283895

P1433

P1476

A novel role of IL-17-producin ...... e disease in multiple myeloma.

@en

P2093

Drew Pardoll

http://www.w3.org/2001/XMLSchema#string

G David Roodman

http://www.w3.org/2001/XMLSchema#string

Ivan Borrello

http://www.w3.org/2001/XMLSchema#string

Judy Anderson

http://www.w3.org/2001/XMLSchema#string

Kimberly Noonan

http://www.w3.org/2001/XMLSchema#string

P2860

Bioconductor: open software development for computational biology and bioinformatics

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice

TH17 cells in development: an updated view of their molecular identity and genetic programming

STAT3 regulates cytokine-mediated generation of inflammatory helper T cells

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways

P304

3554-3563

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2010-05-283895

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Luigi Marchionni

P577

2010-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45389008

http://www.w3.org/2001/XMLSchema#string

P698

20664052

http://www.w3.org/2001/XMLSchema#string

P921

P932

4017298

http://www.w3.org/2001/XMLSchema#string